OUR MISSION

 

To equip women’s healthcare providers with advanced AI medical device technologies for the detection of cervical cancer

 

Cervical cancer is the fourth most common cancer affecting women globally and the second most common cancer for women in low resource settings.
Lack of infrastructure, low availability of resources, together with a shortage of trained medical staff have led to limited access to cervical cancer screening and treatment.

 

Improving access to expert care with the EVA System.
Our Enhanced Visual Assessment (EVA) System is an FDA cleared and CE marked mobile colposcope used to visualize the cervix. With high-quality optics, secure image and video capture, and online data management system, EVA drastically improves accessibility to expert care with its telemedicine and AI clinical decision support capabilities.

 

PARTNERS

LEADERSHIP

Leon A. Boston

Leon A. Boston

CEO

Dan Geffen

Dan Geffen

VP Finance

Yaniv Almog

Yaniv Almog

VP R&D

Lior Shwarzwald

Lior Shwarzwald

Head of Product

BOARD OF DIRECTORS

Nissim Darvish, MD, PhD

Nissim Darvish, MD, PhD

Senior Managing Director, Orbimed

Paul Swinney

Paul Swinney

Co-Founder, Tristel

Ruth Shaber, MD

Ruth Shaber, MD

Founder and President of the Tara Health Foundation

Jonathan Fleming

Jonathan Fleming

Chairman of the Board

ADVISORS

Liora Bowers

Health Economics

Paul Blumenthal, MD

Cervical Cancer

Stan Lapidus

Founder of Cytyc and Exact

Lee Newcomer, MD

US Payers

Cherissa Jackson

Public Health

Tony Estrella

Global Insurance

Bruce Khan, MD

Gynecology

TEAM MobileODT

We are building a world-class digital health company, together. Technologists, doers, dreamers, and changemakers committed to helping dedicated health workers worldwide better serve their communities. 

Pin It on Pinterest